Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Nabeel Abdulrahman"'
Autor:
Iman W. Achkar, Nabeel Abdulrahman, Hend Al-Sulaiti, Jensa Mariam Joseph, Shahab Uddin, Fatima Mraiche
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-12 (2018)
Abstract Cisplatin is a widely used chemotherapeutic agent for treatment of various cancers. However, treatment with cisplatin is associated with drug resistance and several adverse side effects such as nephrotoxicity, reduced immunity towards infect
Externí odkaz:
https://doaj.org/article/d58a3f91f9b7434e85cbae1e0644bc92
Autor:
Imen Saadaoui, Rihab Rasheed, Nabeel Abdulrahman, Touria Bounnit, Maroua Cherif, Hareb Al Jabri, Fatima Mraiche
Publikováno v:
Marine Drugs, Vol 18, Iss 4, p 197 (2020)
Lung cancer is one of the major causes of death worldwide. Natural molecules with anti-lung cancer potential are of a great interest and considered as very promising alternative to substitute or enhance the efficiency of the conventional drugs. Recen
Externí odkaz:
https://doaj.org/article/266c8285aa9c404492e4fdf2870457c3
Autor:
Iman A Mohamed, Alain-Pierre Gadeau, Larry Fliegel, Gary Lopaschuk, Mohamed Mlih, Nabeel Abdulrahman, Natasha Fillmore, Fatima Mraiche
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0123318 (2015)
Enhanced expression and activity of the Na+/H+ exchanger isoform 1 (NHE1) has been implicated in cardiomyocyte hypertrophy in various experimental models. The upregulation of NHE1 was correlated with an increase in osteopontin (OPN) expression in mod
Externí odkaz:
https://doaj.org/article/ff6a49340365414ebd1606dcacf21e2a
Autor:
Nabeel Abdulrahman, Meram Ibrahim, Jensa Mariam Joseph, Hanan Mahmoud Elkoubatry, Al-Anood Al-Shamasi, Menatallah Rayan, Alain Pierre Gadeau, Rashid Ahmed, Hussein Eldassouki, Anwarul Hasan, Fatima Mraiche
Publikováno v:
Molecular and Cellular Biochemistry
Molecular and Cellular Biochemistry, 2022, Online ahead of print. ⟨10.1007/s11010-022-04411-6⟩
Molecular and Cellular Biochemistry, 2022, Online ahead of print. ⟨10.1007/s11010-022-04411-6⟩
Diabetes mellitus (DM)-induced cardiac morbidities have been the leading cause of death among diabetic patients. Recently, sodium-glucose cotransporter-2 (SGLT-2) inhibitors including empagliflozin (EMPA), which have been approved for the treatment o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23d4de6abc3f3b0cf7c15ff79df15d92
https://doi.org/10.1007/s11010-022-04411-6
https://doi.org/10.1007/s11010-022-04411-6
Autor:
Fatima Mraiche, Anwarul Hasan, Nabeel Abdulrahman, Shahab Uddin, Kodappully Sivaraman Siveen, Aisha Osman, Huseyin C. Yalcin, Jensa Mariam Joseph
Objective Cisplatin is a standard treatment approach against lung adenocarcinoma. Resistance to cisplatin and the toxic side effects of cisplatin continue to remain a challenge. Combining drugs with different mechanisms is being investigated as a mea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5368a5cea9debf5ebf0a2f6cf7b54198
https://hdl.handle.net/10576/15419
https://hdl.handle.net/10576/15419
Empagliflozin (EMPA), an SGLT2 inhibitor (with a low affinity for SGLT1) has attracted much attention due to a recent clinical trial, the Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes (EMPA-REG OUTCOME). In this trial, trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d12fee6f2f456cdf81d0ab79ca2c4e60
https://hdl.handle.net/10576/16811
https://hdl.handle.net/10576/16811
Autor:
Atulya Manuel, Nabeel Abdulrahman
Publikováno v:
International Journal of Current Microbiology and Applied Sciences. 6:1140-1147
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3d6600d497dd48a8739205093ef30a7
https://doi.org/10.20546/ijcmas.2017.608.141
https://doi.org/10.20546/ijcmas.2017.608.141
Autor:
Béatrice Jaspard-Vinassa, Larry Fliegel, Nabeel Abdulrahman, Aayesha Jabeen, Fatima Mraiche, Alain-Pierre Gadeau, Sadaf Riaz
Publikováno v:
Physiological Genomics
Physiological Genomics, American Physiological Society, 2018, 50 (5), pp.332-342. ⟨10.1152/physiolgenomics.00133.2017⟩
Physiological Genomics, 2018, 50 (5), pp.332-342. ⟨10.1152/physiolgenomics.00133.2017⟩
Physiological Genomics, American Physiological Society, 2018, 50 (5), pp.332-342. ⟨10.1152/physiolgenomics.00133.2017⟩
Physiological Genomics, 2018, 50 (5), pp.332-342. ⟨10.1152/physiolgenomics.00133.2017⟩
Cardiovascular diseases are the leading cause of death worldwide. One in three cases of heart failure is due to dilated cardiomyopathy. The Na+/H+ exchanger isoform 1 (NHE1), a multifunctional protein and the key pH regulator in the heart, has been d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cca7166ef0c4ae29e6cad469cec8d1c
https://www.hal.inserm.fr/inserm-02518882
https://www.hal.inserm.fr/inserm-02518882
Publikováno v:
Life sciences. 209
Cardiac remodeling, characterized by excessive extracellular matrix (ECM) remodeling, predisposes the heart to failure if left unresolved. Understanding the signaling mechanisms involved in excessive extracellular matrix (ECM) remodeling is necessary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::757e70f6b73d71bda4dd98fdb3dd1aa4
https://pubmed.ncbi.nlm.nih.gov/30089233
https://pubmed.ncbi.nlm.nih.gov/30089233
Publikováno v:
Qatar Foundation Annual Research Conference Proceedings Volume 2018 Issue 2.
Background: Extracellular matrix (ECM) remodeling is a characteristic feature of cardiac remodeling which, if left untreated, progresses to heart failure. Cardiac fibroblasts, the major cellular component of the myocardium, are responsible for mainta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::455287183f7a447bf25a6691645aa901
https://doi.org/10.5339/qfarc.2018.hbpd473
https://doi.org/10.5339/qfarc.2018.hbpd473